Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Interim analysis from a phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer: APGOT-ov4/ OPEB-01.
- Authors
- Lee, JY[Lee, Jung-Yun]; Kim, JW[Kim, Jae-Weon]; Kim, BG[Kim, Byoung-Gie]; Kim, SW[Kim, Sang Wun]; Kim, HS[Kim, Hee Seung]; Kim, SI[Kim, Se Ik]; Lim, MC[Lim, Myong Cheol]; Choi, CH[Choi, Chel Hun]; Ngoi, N[Ngoi, Natalie]; Tan, DSP[Tan, David Shao Peng]; Kim, YN[Kim, Yoo Na]
- Issue Date
- 1-Jun-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.16, pp.E17579 - E17579
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 16
- Start Page
- E17579
- End Page
- E17579
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.